Hepatitis C inhibitor compound

Details Hepatitis C inhibitor compound Hepatitis C inhibitor compound

2005-07-19

2005-07-19

Tate, Christopher (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Synthesis of peptides

C514S002600

Reexamination Certificate

active

06919423

ABSTRACT:
Compounds of formula (I):wherein B, X, R3, R21, R22, R1and Rcare defined herein. The compounds are useful as inhibitors of HCV NS3 protease.

REFERENCES:
patent: 6323180 (2001-11-01), Llinas-Brunet et al.
patent: 6329379 (2001-12-01), Llinas-Brunet et al.
patent: 6410531 (2002-06-01), Llinas-Brunet et al.
patent: 6420380 (2002-07-01), Llinas-Brunet et al.
patent: 6534523 (2003-03-01), Llinas-Brunet et al.
patent: 6642204 (2003-11-01), Llinas-Brunet et al.
patent: WO 99/07733 (1999-02-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None

Affiliated with

Also associated with

Rating

Hepatitis C inhibitor compound does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatitis C inhibitor compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C inhibitor compound will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3403596